Davis Asset Management L.P. bought a new position in shares of Merck KGaA (OTCMKTS:MKGAF – Free Report) during the 2nd quarter, according to the company in its most recent filing with the SEC. The fund bought 4,000 shares of the company’s stock, valued at approximately $514,000.
A number of other large investors have also modified their holdings of MKGAF. Bank of Nova Scotia acquired a new stake in shares of Merck KGaA in the 2nd quarter valued at approximately $281,696,000. Danske Bank A S purchased a new stake in shares of Merck KGaA in the second quarter valued at approximately $276,535,000. Korea Investment CORP acquired a new position in Merck KGaA during the second quarter worth $239,191,000. Great Lakes Advisors LLC acquired a new position in Merck KGaA during the second quarter worth $183,444,000. Finally, Commerce Bank purchased a new position in Merck KGaA in the second quarter worth $159,152,000. 0.10% of the stock is owned by hedge funds and other institutional investors.
Merck KGaA Trading Up 0.7%
OTCMKTS:MKGAF opened at $163.21 on Friday. Merck KGaA has a 1 year low of $116.68 and a 1 year high of $175.56. The company has a debt-to-equity ratio of 0.27, a quick ratio of 0.84 and a current ratio of 1.31. The stock has a fifty day moving average price of $162.62 and a two-hundred day moving average price of $148.46. The stock has a market capitalization of $21.09 billion, a price-to-earnings ratio of 24.92 and a beta of 0.96.
Merck KGaA Company Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Recommended Stories
- Five stocks we like better than Merck KGaA
- 2 Biotech Stocks Shaping Up for Major Breakouts
- 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs
- 3 Beaten-Down Stocks That Haven’t Gotten the Message About the S&P 500’s Record Run
- Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit?
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
